Testicular cancer treated in a minor general oncology department

European Journal of Cancer

Volumn 31, Issue 3, 1995, Pages 293-295

  Norum, J ^a   Nordoy T ^a   Wist, E ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; SEMINOMA; TESTIS CANCER;

ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; FOLLOW-UP STUDIES; HUMAN; LACTATE DEHYDROGENASE; MALE; MIDDLE AGE; NEOPLASM STAGING; NORWAY; ONCOLOGY SERVICE, HOSPITAL; REMISSION INDUCTION; SEMINOMA; SURVIVAL RATE; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0028958377     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(94)00448-E     Document Type: Article

References (20)

1. Survival of patients with cancer. Those included in clinical trials do better
2. Update on survival from cancer — cancer centre vs peripheral hospital. Clinical trial vs standard treatment
3. What sort of oncology team should treat testicular teratoma
4. Hodgkin's disease: no stage beyond cure
5. Who should treat Hodgkin's disease — and where?
6. Histological typing of testis tumours
7. The combined management of malignant teratoma of the testis
8. The treatment of metastatic germ cell testicular tumours with bleomycin, etoposide and cisplatin (BEP)
9. Testicular cancer
10. Testicular carcinoma in Denmark 1976–1980. Stage and selected clinical parameters at presentation
11. Testicular germ-cell tumours in Denmark 1976–1980. Pathology of 1058 consecutive cases
12. Testicular cancer in young Norwegians
13. Prognostic factors in clinical stage I nonseminomatous germ cell tumours of the testis. Multivariate analysis of a prospective multicenter study
14. Testicular cancer
15. Tumour markers in testicular germ cell tumours Five years experience from the DATECA study 1976–1980
16. Prognostic factors in advanced non-seminomatous germ cell testicular tumours. Results of a multicentre study
17. Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer. Results from a European organisation for research on treatment of cancer multiinstitutional phase III study
18. Cancer of the testis
19. Treatment of testicular teratoma in general oncology departments
20. Surviving malignant disease. Psychological and family aspects